Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000362183 | SCV000337006 | uncertain significance | not provided | 2015-11-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002518926 | SCV003511027 | pathogenic | Spastic paraplegia | 2023-05-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro22Leufs*7) in the VAMP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VAMP1 are known to be pathogenic (PMID: 28253535). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with VAMP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 284396). For these reasons, this variant has been classified as Pathogenic. |